rs6010209

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1

The NM_020461.4(TUBGCP6):ā€‹c.3288T>Gā€‹(p.Asp1096Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000661 in 1,528,310 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00046 ( 0 hom., cov: 33)
Exomes š‘“: 0.000035 ( 0 hom. )

Consequence

TUBGCP6
NM_020461.4 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: -7.18
Variant links:
Genes affected
TUBGCP6 (HGNC:18127): (tubulin gamma complex component 6) The protein encoded by this gene is part of a large multisubunit complex required for microtubule nucleation at the centrosome. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.007681191).
BP6
Variant 22-50221071-A-C is Benign according to our data. Variant chr22-50221071-A-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 966787.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2}. Variant chr22-50221071-A-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000456 (52/114106) while in subpopulation AFR AF= 0.00168 (49/29182). AF 95% confidence interval is 0.0013. There are 0 homozygotes in gnomad4. There are 23 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TUBGCP6NM_020461.4 linkuse as main transcriptc.3288T>G p.Asp1096Glu missense_variant 16/25 ENST00000248846.10 NP_065194.3
TUBGCP6XR_001755343.3 linkuse as main transcriptn.3852T>G non_coding_transcript_exon_variant 16/20
TUBGCP6XR_938347.3 linkuse as main transcriptn.3852T>G non_coding_transcript_exon_variant 16/23
TUBGCP6XR_007067982.1 linkuse as main transcriptn.3048+957T>G intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TUBGCP6ENST00000248846.10 linkuse as main transcriptc.3288T>G p.Asp1096Glu missense_variant 16/251 NM_020461.4 ENSP00000248846 P1Q96RT7-1
TUBGCP6ENST00000439308.6 linkuse as main transcriptc.3288T>G p.Asp1096Glu missense_variant 16/251 ENSP00000397387
TUBGCP6ENST00000498611.5 linkuse as main transcriptn.3617+204T>G intron_variant, non_coding_transcript_variant 1
TUBGCP6ENST00000491449.5 linkuse as main transcriptn.1595T>G non_coding_transcript_exon_variant 8/165

Frequencies

GnomAD3 genomes
AF:
0.000447
AC:
51
AN:
114020
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00165
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000177
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000639
GnomAD3 exomes
AF:
0.0000717
AC:
18
AN:
251208
Hom.:
0
AF XY:
0.0000589
AC XY:
8
AN XY:
135802
show subpopulations
Gnomad AFR exome
AF:
0.000923
Gnomad AMR exome
AF:
0.0000872
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000346
AC:
49
AN:
1414204
Hom.:
0
Cov.:
37
AF XY:
0.0000298
AC XY:
21
AN XY:
704372
show subpopulations
Gnomad4 AFR exome
AF:
0.00111
Gnomad4 AMR exome
AF:
0.000117
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.26e-7
Gnomad4 OTH exome
AF:
0.000141
GnomAD4 genome
AF:
0.000456
AC:
52
AN:
114106
Hom.:
0
Cov.:
33
AF XY:
0.000416
AC XY:
23
AN XY:
55318
show subpopulations
Gnomad4 AFR
AF:
0.00168
Gnomad4 AMR
AF:
0.000176
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000631
Alfa
AF:
0.000136
Hom.:
0
Bravo
AF:
0.000366
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000906
AC:
11

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Microcephaly and chorioretinopathy 1 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsAug 11, 2021- -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 07, 2023This sequence change replaces aspartic acid, which is acidic and polar, with glutamic acid, which is acidic and polar, at codon 1096 of the TUBGCP6 protein (p.Asp1096Glu). This variant is present in population databases (rs6010209, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with TUBGCP6-related conditions. ClinVar contains an entry for this variant (Variation ID: 966787). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The glutamic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 09, 2023This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.0050
DANN
Benign
0.57
DEOGEN2
Benign
0.016
T;.
Eigen
Benign
-2.5
Eigen_PC
Benign
-2.6
FATHMM_MKL
Benign
0.023
N
LIST_S2
Benign
0.44
T;T
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.0077
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.77
N;.
MutationTaster
Benign
0.99
N;N
PrimateAI
Benign
0.28
T
PROVEAN
Benign
0.0
N;N
REVEL
Benign
0.027
Sift
Benign
0.32
T;T
Sift4G
Benign
0.72
T;T
Polyphen
0.44
B;.
Vest4
0.10
MutPred
0.33
Loss of loop (P = 0.0986);Loss of loop (P = 0.0986);
MVP
0.20
MPC
0.14
ClinPred
0.032
T
GERP RS
-8.8
Varity_R
0.023
gMVP
0.13

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6010209; hg19: chr22-50659500; API